Vor Biopharma Inc.
VOR | NASDAQ
$23.18
+$1.29 (+5.89%)
Sep 22, 2026, 2:06 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.19 | -0.65 | -1.29 | -2.85 | -6.15 | -28.20 |
PEG Ratio | 0 | 0.23 | 0.05 | -0.12 | -0.15 | -0.09 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -0.79 | 0.79 | 1 | 1.05 | 2 | 28.84 |
P/FCF Ratio | -0.90 | -0.76 | -1.49 | -2.81 | -5.91 | -34.42 |
P/OCF Ratio | -0.90 | -0.77 | -1.51 | -3.09 | -6.25 | -38.36 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.02 | 0.33 | 0.24 | 0.16 | 0.08 | 0.38 |
Quick Ratio | 18.20 | 5.19 | 9.04 | 18.06 | 21.12 | 4.81 |
Current Ratio | 18.20 | 5.19 | 9.04 | 18.06 | 21.12 | 4.81 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 423.57% | -120.95% | -78.20% | -36.75% | -31.86% | -89.78% |
Return on Assets | -149.96% | -81.82% | -56.17% | -30.76% | -28.40% | -57.09% |
Return on Invested Capital | -84.61% | -94.31% | -63.63% | -32.27% | -29.46% | -65.15% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove VOR